Expert Opinion on Pharmacotherapy, Volume 23, Issue 11 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Pharmacotherapy, Volume 23, Issue 11 (2022)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Volume 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000
Download citations Download PDFs Download issue

Editorial

Editorial
Identifying the challenges for successful pharmacotherapeutic management of sarcopenia
Gordon S. Lynch
Pages: 1233-1237
Published online: 18 May 2022
First Page PreviewforIdentifying the challenges for successful pharmacotherapeutic management of sarcopenia | Full Text | References | PDF (173.6 KB) | EPUB
  • 1780 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Selecting appropriate therapy for hairy cell leukemia: current state and future prospects based on molecularly defined characterization
Constantin A. Dasanu, Juliana Alvarez-Argote & Catherine B Goff
Pages: 1239-1241
Published online: 15 Jun 2022
First Page PreviewforSelecting appropriate therapy for hairy cell leukemia: current state and future prospects based on molecularly defined characterization | Full Text | References | PDF (138.1 KB) | EPUB
  • 956 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Editorial
When is pharmacotherapy necessary for the treatment of seasonal affective disorder?
Jean-Baptiste Belge, Amber CF Sabbe & Bernard GCC Sabbe
Pages: 1243-1245
Published online: 12 Jul 2022
First Page PreviewforWhen is pharmacotherapy necessary for the treatment of seasonal affective disorder? | Full Text | References | PDF (151.2 KB) | EPUB
  • 1872 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Pharmacoeconomic Evaluation

Article
A systematic review of economic evaluations of tyrosine kinase inhibitors for non-small cell lung cancer (NSCLC)
Joo-Young Byun, Sun-Kyeong Park, Boon Peng Ng, Yi-Shao Liu, Chae-Rin Kim & Chanhyun Park
Pages: 1247-1257
Published online: 04 Jul 2022
AbstractforA systematic review of economic evaluations of tyrosine kinase inhibitors for non-small cell lung cancer (NSCLC) | Full Text | References | PDF (588.5 KB) | EPUB | Supplemental
  • 239 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

The role of Recent Pharmacotherapeutic Options on the Management of Treatment Resistant Type 2 Diabetes
Jeffrey M. Kroopnick & Stephen N. Davis
Pages: 1259-1271
Published online: 28 Jun 2022
AbstractforThe role of Recent Pharmacotherapeutic Options on the Management of Treatment Resistant Type 2 Diabetes | Full Text | References | PDF (1 MB) | EPUB
  • 230 Views
  • 1 CrossRef citations
  • 0Altmetric
The pharmacotherapeutic management of nail unit and acral melanomas
Julianne M. Falotico & Shari R. Lipner
Pages: 1273-1289
Published online: 14 Jun 2022
AbstractforThe pharmacotherapeutic management of nail unit and acral melanomas | Full Text | References | PDF (4.4 MB) | EPUB
  • 147 Views
  • 2 CrossRef citations
  • 0Altmetric
The landscape of systemic therapy for early stage triple-negative breast cancer
Jin-Yu Lu, Alvaro Alvarez Soto & Jesus D Anampa
Pages: 1291-1303
Published online: 25 Jul 2022
AbstractforThe landscape of systemic therapy for early stage triple-negative breast cancer | Full Text | References | PDF (2.1 MB) | EPUB
  • 327 Views
  • 2 CrossRef citations
  • 0Altmetric
Pharmacotherapy for Alzheimer’s disease: what’s new on the horizon?
Rita Khoury, Amy Gallop, Kelsey Roberts, Noam Grysman, Jiaxi Lu & George T. Grossberg
Pages: 1305-1323
Published online: 11 Jul 2022
AbstractforPharmacotherapy for Alzheimer’s disease: what’s new on the horizon? | Full Text | References | PDF (451.6 KB) | EPUB
  • 415 Views
  • 0 CrossRef citations
  • 0Altmetric
Recently approved and emerging drug options for migraine prophylaxis
Enrico Bentivegna, Michelangelo Luciani, Valeria Ferrari, Silvia Galastri, Francesco Baldari, Francesco Scarso, Piera A. Lamberti & Paolo Martelletti
Pages: 1325-1335
Published online: 25 Jul 2022
AbstractforRecently approved and emerging drug options for migraine prophylaxis | Full Text | References | PDF (380.2 KB) | EPUB
  • 281 Views
  • 2 CrossRef citations
  • 0Altmetric

Systematic Review

Management of schizophrenia in women during the perinatal period: a synthesis of international recommendations
Amaury Lefebvre, Arnaud Pouchon, Stéphanie Bioulac, Jasmina Mallet, Mircea Polosan & Clément Dondé
Pages: 1337-1350
Published online: 19 Jul 2022
AbstractforManagement of schizophrenia in women during the perinatal period: a synthesis of international recommendations | Full Text | References | PDF (2.5 MB) | EPUB | Supplemental
  • 306 Views
  • 0 CrossRef citations
  • 0Altmetric

systematic review

Efficacy and tolerability of pharmacotherapy for obsessive-compulsive personality disorder: a systematic review of randomized controlled trials
Julija Gecaite-Stonciene, Taryn Williams, Christine Lochner, Jacob Hoffman & Dan J. Stein
Pages: 1351-1358
Published online: 15 Jul 2022
AbstractforEfficacy and tolerability of pharmacotherapy for obsessive-compulsive personality disorder: a systematic review of randomized controlled trials | Full Text | References | PDF (625.1 KB) | EPUB
  • 308 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Effect of ipragliflozin on liver enzymes in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
Rizwana Parveen et al.
Review Article | Published online: 28 May 2024
Promising immunomodulators for management of substance and alcohol use disorders
Amanda M. Acuña et al.
Review Article | Published online: 28 May 2024
Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals
Krystyna Dobrowolska et al.
Review Article | Published online: 27 May 2024
Recent advances in pharmacological management of attention-deficit/hyperactivity disorder: moving beyond stimulants
Ann Childress
Review Article | Published online: 27 May 2024
View all latest articles